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Abstract 
Direct application of histone-deacetylase-inhibitors (HDACis) to dental pulp cells (DPCs) 
induces chromatin changes, promoting gene expression and cellular-reparative events. We have 
previously demonstrated that HDACis (Valproic acid, Trichostatin A) increase mineralization in dental 
papillae-derived cell-lines and primary DPCs by stimulation of dentinogenic gene expression. Here, we 
investigated novel genes regulated by the HDACi, suberoylanilide hydroxamic acid (SAHA), to identify 
new pathways contributing to DPC differentiation. SAHA significantly compromised DPC viability only 
at relatively high concentrations (5µM); while low concentrations (1µM) SAHA did not increase 
apoptosis. HDACi-exposure for 24h induced mineralization-per-cell dose-dependently after 2 weeks; 
however, constant 14d SAHA-exposure inhibited mineralization. Microarray analysis (24h and 14d) of 
SAHA exposed cultures highlighted that 764 transcripts showed a significant >2.0-fold change at 24h, 
which reduced to 36 genes at 14d. 59% of genes were down-regulated at 24h and 36% at 14d, 
respectively. Pathway analysis indicated SAHA increased expression of members of the matrix 
metalloproteinase (MMP) family. Furthermore, SAHA-supplementation increased MMP-13 protein 
expression (7d, 14 d) and enzyme activity (48h, 14d). Selective MMP-13-inhibition (MMP-13i) dose-
dependently accelerated mineralization in both SAHA-treated and non-treated cultures. MMP-13i-
supplementation promoted expression of several mineralization-associated markers, however, HDACi-
induced cell migration and wound healing were impaired. Data demonstrate that short-term low-dose 
SAHA-exposure promotes mineralization in DPCs by modulating gene pathways and tissue proteases.  
MMP-13i further increased mineralization-associated events, but decreased HDACi cell migration 
indicating a specific role for MMP-13 in pulpal repair processes. Pharmacological inhibition of HDAC 
and MMP may provide novel insights into pulpal repair processes with significant translational benefit. 
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Introduction 
The balance between the cellular enzymes, histone deacetylases (HDACs) and histone 
acetyltransferases (HATs), controls chromatin conformation and regulates transcription. Predominant 
HDAC activity results in the removal of acetyl groups from the histone tails within the nucleosome, 
leading to a condensed chromatin conformation and reduced transcription, while HAT activity has the 
opposite effect leading to an open, transcriptionally active chromatin structure (Bolden et al., 2006). 
There are 18 identified mammalian HDACs, which are categorized into four classes functioning via zinc-
dependent or independent mechanisms (Gregoretti et al., 2004). Class I (-1, -2, -3, -8) are zinc-dependent, 
ubiquitously distributed and expressed in the cell nucleus (Marks and Dokmanovic, 2005), while class II 
(-4, -5, -6, -9, -10) are also zinc-dependent, but demonstrate tissue-restricted expression and shuttle 
between the nucleus and cytoplasm (Verdin et al., 2003; Marks, 2010). Class III HDACs, known as 
sirtuins, are not zinc-dependent, instead requiring coenzyme nicotinamide adenine dinucleotide (NAD+) 
for function (Haigis and Guarente, 2006), while there is currently only one class IV member, HDAC -11 
(Villagra et al., 2009). A recent analysis of HDAC expression in human dental pulp tissue demonstrated 
that HDAC-2 and -9 were expressed in some pulp cell populations and strongly expressed in 
odontoblasts, the formative cells for mineralized dentin, while HDAC-1, -3 and -4 were only relatively 
weakly expressed within pulp tissue (Klinz et al., 2012), highlighting the tissue-specific expression of 
class I and II of HDAC.  
Histone deacetylase inhibitors (HDACi) are epigenetic-modifying agents that alter the 
homeostatic enzyme balance between HDACs and HATs leading to an increase in acetylation and 
transcription. The increased gene expression induces pleiotropic cellular effects, altering cell growth 
(Marks and Xu, 2009), increasing cell differentiation (Schroeder and Westendorf, 2005), reducing 
inflammation (Shuttleworth et al., 2010) and modulating stem cell lineage commitment (Mahmud et al., 
2014). A range of natural and synthetic HDACi, including valproic acid (VPA), butyric acid, trichostatin 
A (TSA) and suberoylanilide hydroxamic acid (SAHA), have been investigated with SAHA being the 
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first HDACi to gain United States Food and Drug Administration (FDA) approval for anti-cancer 
treatment (Grant et al., 2007). Increasingly, the positive transcriptional effects of HDACi are also being 
investigated in fields such as bone engineering (De Boer et al., 2006), and organ regeneration (de Groh et 
al., 2010).  Traditionally, pan-HDACi (such as VPA, TSA and SAHA), which are active against Class I 
and II HDACs, have been investigated experimentally (Schroeder et al., 2007; Marks, 2010; Jin et al., 
2013).  
Within dental pulp research, a range of HDACis have been demonstrated to promote 
differentiation and increase mineralization dose-dependently, in both a dental-papilla derived cell-line 
(Duncan et al., 2012; Kwon et al., 2012) and primary dental pulp cell (DPC) populations at relatively low 
concentrations (Duncan et al., 2013; Jin et al., 2013; Paino et al., 2014). An HDACi-induced expression 
of specific dentinogenic-marker genes was demonstrated, which may drive the increase in mineralization 
(Duncan et al., 2012; Kwon et al., 2012). Other studies have identified the down-regulation of specific 
class I HDACs, -3 (Jin et al., 2013) and -2 (Paino et al., 2014) in mineralizing pulp cells. At present, no 
study has characterized the transcript regulation and novel pathways responsible for the HDACi-induced 
promotion of pulp mineralization using high-throughput approaches.  
The matrix metalloproteinases (MMPs) are a family of host-derived zinc-dependent 
endopeptidases (Nagase and Woessner Jr, 1999). MMPs can not only degrade practically all 
proteinaceous extracellular matrix components (Verma and Hansch, 2007), but are also an important link 
to a host of tissues processes including angiogenesis, differentiation and chemotaxis by improving the 
bioavailability of growth factors through cleavage (Hannas et al., 2007; Borzi et al., 2010). MMPs have 
been shown to be central to normal and pathological remodelling processes in various mineralization-
associated tissues, including bone (Paiva and Granjeiro, 2014), cartilage (Krane and Inada, 2003) and 
periodontal tissues (Ravanti et al., 1999). Recently, certain MMPs have generated significant interest 
within restorative dentistry with MMP-2 being identified in increased quantity in defensive reactionary 
dentine (Charadram et al., 2012) while MMP-13 (collagenase-3) expression increased during dental 
wound reparative processes (Suri et al., 2008; Yoshioka et al., 2013).  
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From a translation perspective, the identification of regulators that control lineage commitment 
and differentiation is paramount to the development of cell-based regenerative strategies. A complex 
HDAC-mediated control of bone remodelling and repair processes is emerging involving intricate 
epigenetic-control of a series of pathways (Bradley et al., 2011). MMP-13 activity may be particularly 
important in this process as it demonstrates relatively high expression in pulp tissue (Palosaari et al., 
2003; Sulkala et al., 2004), has increased expression during mineralization (Winchester et al., 1999; Suri 
et al., 2008) and repressed-transcription by HDAC-4 in an mineralizing osteoblastic cell-line (Shimizu et 
al., 2010). Notably, microarray studies have demonstrated an HDACi-induced modulation of MMPs in 
mineralizing bone-derived cell cultures (Schroeder et al., 2007). Here for the first time, we investigate 
whether the clinically-approved HDACi, SAHA, could induce regenerative processes in primary DPC 
cultures with high-throughput transcriptional analyses being undertaken to identify novel genes and 
potential pathways activated.  As transcriptomic analysis identified a significant role for several MMPs in 
the pulp reparative process; a subsequent aim of this study was to analyse the specific novel role of MMP-
13 and its interaction with HDACi in modulating regenerative events in DPC cultures. 
 
Materials and methods 
Primary cell isolation and culture. Primary DPCs were isolated from the extirpated pulp tissue of freshly 
extracted rodent incisor teeth using enzymatic disaggregation (Patel et al., 2009). Briefly, teeth were 
dissected from male Wistar Hannover rats aged 25-30 days and weighing 120-140 g. Pulp tissue was 
extirpated, minced and transferred into Hank’s balanced salt solution (Sigma-Aldrich, Arklow, Ireland) 
prior to incubation at 37°C, 5% CO2 for 30 min (MCO-18AC incubator, Sanyo Electric, Osaka, Japan). 
Cells were transferred to an equal volume of supplemented α-MEM (Biosera, East Sussex, UK) 
containing 1% (w/v) penicillin/streptomycin (Sigma-Aldrich) and 10% (v/v) foetal calf serum (FCS) 
(Biosera). Single cells were obtained by passing through a 70 µm cell sieve (BD Biosciences) prior to 
centrifugation and re-suspension in 1 ml supplemented α-MEM. DPCs were expanded under standard 
culture conditions to passage 2 for use in all subsequent experiments.  
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Pharmacological inhibitor preparation. A 5 mM stock solution of the HDACi, SAHA (N-hydroxy-N′-
phenyl-octanediamide) (Sigma-Aldrich), in dimethyl sulfoxide (DMSO) was diluted in phosphate 
buffered saline (PBS) (Sigma-Aldrich) prior to further dilution to experimental concentrations (0.25 µM - 
5 µM) with supplemented α-MEM. A 5 mM stock solution of the MMP-13 specific inhibitor (MMP-13i) 
(Pyrimidine-4,6-dicarboxylic acid, Bis-[4-fluoro-3-methyl-benzylamide])  (Santa Cruz Biotechnologies, 
Heidelberg, Germany) in dimethyl sulfoxide (DMSO) was diluted to experimental concentrations (0.5 
µM - 10 µM) in supplemented α-MEM. 
 
Cell growth and viability analysis. DPCs were initially seeded 1 x 10
5
 cells per well [6-well plates 
(Sarstedt, Wexford, Ireland)] for 72 h. For experimental day 0, cells were cultured in supplemented α-
MEM for a further 24 h prior to harvest. SAHA (0.25, 0.5, 1, 3 and 5 µM) was added to the supplemented 
α-MEM at day 0. Control samples did not contain SAHA supplementation. Trypan blue (Sigma-Aldrich) 
staining (n=4) was used to assess cell viability.  Thereafter 1 and 2 µM MMP-13i alone or in combination 
with SAHA were assessed for effects on DPC growth and viability under mineralizing conditions.  Cells 
were seeded as previously described and at 72 h (experimental day 0), mineralizing medium 
(supplemented α-MEM including 50 µg/ml ascorbic acid, 0.1 µM dexamethasone and 10 mM β-
glycerophosphate) was applied for a further 1 and 4 days. As 24 h HDACi culture had previously been 
demonstrated in induce mineralization at 14 days (Duncan et al., 2013), SAHA (1 µM) was added to the 
mineralizing medium, at day 0, for the initial 24 h only, while the MMP-13i was supplemented in cultures 
throughout. In the 5 day group, the SAHA/MMP-13i-supplemented mineralizing medium was replaced 
after 24 h with MMP-13i-supplemented mineralization media for a further 4 days. Control cultures were 
in mineralizing medium either without HDACi or MMP-13i. Three independent experiments (n=3) were 
performed in triplicate for time points and combinations of SAHA and 1 µM, 2 µM MMP-13i, 
respectively.  
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Live-Dead staining assay. DPCs were seeded at a density of 5 x 10
3
 in clear bottom black 96-well plates 
(Corning, NY, USA) for 24 h. At 24 h (experimental day 0), the cells were cultured in mineralizing 
medium for 24 or 48 h (experimental day 1 and 2) prior to harvest. SAHA (0.25, 0.5, 1, 3 and 5 µM) was 
added to the medium at day 0. Control cultures contained mineralization α-MEM without SAHA, while 
1% saponin (Sigma-Aldrich) was applied for 10-15 min to verify cell death. At experimental end-points, 
cultures were washed twice in PBS prior to incubation with Live/Dead™ reagents, 4 µM ethidium 
homodimer-1 (EthD-1) and 2 µM calcein AM (Life Technologies, Paisley, UK) (Murphy et al., 1998).  
Fluorescent signals were quantified spectrophotometrically (Tecan Genios Spectrophotometer, Unitech, 
Dublin, Ireland). Four independent experiments (n=4) were performed in triplicate for each HDACi 
concentration. 
 
Flow cytometry (FC). FC detection (BD FACSCanto II, BD Biosciences) of annexin V (AV) binding and 
propidium iodide (PI) staining (Annexin V-FITC Kit, BD Bioscience) was performed to assess viability 
and apoptosis. Cells (1 x 10
5
 per well in 6-well plates) were cultured in supplemented α-MEM for 24 h, 
prior to addition of SAHA (1 µM) for a further 24 h. The experimental SAHA concentration and 24 h 
time point was selected from the results of the cell growth, live/dead and mineralization assays and 
represented the end of the DPCs exposure to the HDACi. Untreated cells in supplemented α-MEM served 
as the negative control and cells in supplemented α-MEM with 6 µM camptothecin (Sigma-Aldrich) were 
used as a positive control to confirm apoptosis. Cells were detached (trypsin/EDTA), washed twice with 
PBS and suspended in a 1 x AV binding buffer (BD Bioscience). A 100 µl aliquot of the cell suspension 
(1 x 10
5
) was incubated at room temperature with 5 µl FITC-AV and 5 µl PI for 15 min. Thereafter, 400 
µl of 1 x AV binding buffer was added and cells analysed by FC within 1 h. Excitation was performed at 
488 nm and the emission filters used for AV-FITC and PI were 530/530 nm and 585/545 nm, 
respectively. Data were analysed using FC software (FloJo, Tree Star, OR, USA) and the PI staining 
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intensity plotted against FITC intensity. Four independent experiments (n=4) were performed with 10,000 
cell events measured for each experimental/control group. 
 
Mineralization assays. Cells were seeded (5 x 10
4 
per well
 
in 6-well plates) and cultured in supplemented 
α-MEM for 72 h. At 72 h (day 0), DPCs were supplemented with mineralizing medium with SAHA 
(0.25, 0.5, 1, 3 and 5 µM) for the initial 24 h or for 14 days. In the 24 h HDACi-exposure cultures, 
SAHA-supplemented mineralizing medium was removed after 24 h, prior to culture with an HDACi-free 
mineralizing medium for a further 13 days, while in the 14 day HDACi-exposure samples SAHA 
supplemented the mineralizing medium throughout. The 14 day time-point was selected as rat DPCs in 
mineralizing culture require this time to secrete mineral that can be discriminatively measured 
quantitatively by alizarin red staining (Duncan et al., 2013). Control samples were in mineralizing 
medium without SAHA with medium changes every 3 days. For analysis, cultures were washed 3 times 
for 5 minutes in PBS and fixed in 10% formaldehyde for 15 min, washed with distilled water and finally 
stained with 1.37% (w/v) alizarin red S (Millipore, Cork, Ireland) (pH 4.2) for 15 min at room 
temperature. Excess stain was removed by washing with distilled water; the residual stain was solubilised 
in 10% (v/v) acetic acid (Millipore). Stain intensity was quantified spectrophotometrically at 405 nm 
(Gregory et al., 2004) (Tecan Genios Spectrophotometer, Unitech). Mineral production per cell data for 
all concentrations of SAHA were subsequently calculated based on parallel experiments whereby viable 
cells were counted following Trypan blue staining. Four independent mineralization and cell count 
experiments (n=4) were performed in triplicate for both 24 h and 14 day SAHA exposures, respectively. 
To assess the effects of 1 and 2 µM MMP-13i +/- SAHA on DPC mineralization, a similar 
protocol to that described above was applied. At 72 h, the DPCs were cultured (day 0) in a mineralizing 
medium with the addition of MMP-13i (1 µM or 2 µM) alone or in combination with 1 µM SAHA. DPCs 
were cultured with SAHA for only the initial 24 h, prior to culture with an HDACi-free mineralizing 
medium for a further 13 days, while MMP-13i was supplemented in cultures for the 14 day experimental 
Page 8 of 88
John Wiley & Sons, Inc.
Journal of Cellular Physiology
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
 
 
 
 
9 
 
period. The control samples contained DPCs cultured in mineralizing medium in the presence and 
absence of SAHA. Three independent experiments (n=3) were performed in triplicate for all 
combinations of SAHA and MMP-13i, respectively. 
 
RNA, cDNA and labelled cRNA preparation. Cells were seeded (6 x 10
4 
cells per well) in a 6-well culture 
dish in supplemented α-MEM for 72 h. At 72 h (experimental day 0), cells were either cultured for 24 h 
in supplemented mineralizing medium containing 1 µM SAHA prior to harvest (24 h samples) or 
incubated with an HDACi-free mineralizing medium for a further 13 days (experimental day 14). 
Medium was changed every 3 days in the 14 days group. Control samples contained cells cultured in 
mineralizing medium without SAHA. Cultures were detached (trypsin/EDTA), homogenized [T10 basic 
S2-Ultra-Turrax tissue disrupter (IKA, Staufen, Germany)] and RNA extracted using the RNeasy mini kit 
(Qiagen, West Sussex, UK)and quantified spectrophotometrically (Nanodrop 2000, Thermo Fisher 
Scientific).  For microarray samples, a 75 ng aliquot of total RNA was labelled with Cyanine 3-CTP or 
Cyanine 5-CTP using the Two-Color Low Input Quick Amp labeling Kit (Agilent Technologies, Cork, 
Ireland) according to the manufacturer’s instructions. Briefly, RNA was converted to cDNA with an oligo 
dT-promoter primer and Affinity-Script-RT (Agilent Technologies), prior to experimental/control groups 
being labelled with Cy5 or Cy3 and transcribed to cRNA (Agilent Technologies). The labelled and 
amplified cRNA was purified as previously described using the RNeasy mini kit (Qiagen) and Cy3, Cy5 
concentration, RNA absorbance 260/280 nm and cRNA concentrations determined 
spectrophotometrically (Nanodrop 2000, Wilmington, DE, USA). This enabled specific activity and target 
yields to be calculated prior to microarray experimentation. 
 
Gene expression microarray and data analysis. The Agilent 4 x 44k v3 whole rat genome oligonucleotide 
gene expression microarray (Agilent Technologies) was used to analyse the transcript profiles of SAHA 
treated (1 µM) and untreated DPC cultures at both 24h and 14 days. The microarray analyses were 
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performed on quadruplicate independent DPC cultures (n=4) at both time-points. A total of 825 ng of 
labelled cRNA from each sample (treated and untreated) was loaded onto an individual array according to 
the manufacturer’s instructions and co-hybridised at 65°C for 17 h, washed and scanned in GenePix- 
Personal 4100A, Pro 6.1 (Axon, Molecular Devices, CA, USA) at a resolution of 5 µm. Raw data were 
exported to GeneSpring GX12 and signals for each replicate spot were background corrected and 
normalized using Lowess transformation. Log2 fluorescent intensity ratios were generated for each 
replicate spot and averaged. Genes that were differentially expressed (>2.0 fold) in the SAHA group 
relative to control were identified after passing a t-test (p<0.05), post-hoc test (Storey with Bootstrapping) 
with a corrected q value of 0.05. Genes in the expression data sets were first ‘ranked’ based on Log2 
values from highest to lowest for both groups at both time points, prior to hierarchical clustering being 
used to group gene expression in each condition using the default settings in Genespring GX12. Gene 
Ontology (GO) was evaluated using Go-Elite (http://www.genmapp.org/go_elite) (Salomonis et al., 
2009), which is designed to identify a minimal non-redundant set of biological Ontology terms or 
Pathways to describe a particular set of genes or metabolites. Subsequent pathway analysis was 
undertaken using Pathvisio (http://www.pathvisio.org/) (van lersel et al., 2008; Kelder et al., 2012), which 
uses an over-representation analysis, only reporting on GO terms and pathways with a z score >2, a 
permutation p<0.01, and three or more regulated genes for the pathway. Microarray data have been 
submitted to Gene Expression Omnibus (GEO), accession number: GSE67175. 
 
cDNA synthesis and quantitative RT-PCR analysis. For quantitative validation, DPCs were cultured and 
harvested at 24 h and 14 days in an identical protocol to microarray analysis above. MMP-13i 
supplemented cultures were harvested at 24 h and 5 days. Briefly, at experimental day 0 (72 h), the cells 
were cultured in supplemented mineralizing medium containing 2 µM MMP-13i and harvested at 24 h 
and 5 days. Two control groups contained cells cultured in mineralizing medium in both the presence and 
absence of 24 h 1 µM SAHA. This time point coincided with both the SAHA microarray data and the 
MMP-13i cell growth study. RNA was isolated as described above, converted to single-stranded cDNA 
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using the TaqMan™ reverse transcriptase kit and 50 µM random hexamers (Life Technologies), prior to 
cDNA concentrations being determined spectrophotometrically at 260 nm (Nanodrop 2000, Thermo 
Fisher Scientific).  
The q-RT-PCR analysis was performed for rat genes using specific primers (Invitrogen, Life 
Technologies, Thermo Scientific, Paisley, UK). The primer sequences, product sizes and the accession 
number are listed in Table 1. Synthesised cDNA was amplified in a reaction containing; 12.5 µl SYBR 
Green Fast PCR reagent (Applied Biosystems), 1 µl Forward /Reverse primer, 8 µl DEPC-treated water 
and 100 ng of template cDNA. PCRs were performed using the Applied Biosystems 7500 Fast Real-Time 
PCR thermal cycler (Applied Biosystems) and subjected to a designated number of amplification cycles 
(40 cycles), where a typical cycle was 95°C for 3 secs and 60°C for 30 secs. Real-time PCR data were 
normalized to β-actin, and fold change in gene expression was obtained using the formula 2
((Ctctrl - Ctβ-actin) - 
(Ctexp - Ct-actin))
, where Ct is the threshold cycle, ctrl is the control and exp is the experimental samples. Four 
independent experiments (n=4) were performed for each target gene in triplicate at both 24 h and 14 days 
to validate the microarray data. Three independent experiments (n-3) were carried out in triplicate for the 
MMP-13i experimental gene targets. 
 
Enzyme-Linked Immunosorbent Assay (ELISA). Cells were seeded (6 x 10
4
 per well) in 6-well plates and 
cultured in supplemented α-MEM for 72 h. At 72 h, the DPCs were cultured (day 0) in a mineralizing 
medium with addition of 1 µM SAHA for the initial 24 h of culture. Cells were harvested at experimental 
days 1, 7, 14, and 21 for analysis. The HDACi-supplemented mineralizing medium was removed after 24 
h prior to culture with an HDACi-free mineralizing medium for a further 6, 13 or 20 days. The 
quantification of the MMP-13 protein was investigated at 3 time-intervals, prior to the 21 day 
mineralization end point. Control culture samples did not contain SAHA supplementation. Subsequently, 
medium was aspirated and cultures washed twice in ice cold PBS (pH 7.4), prior to the addition of 300 µl 
lysis buffer containing mammalian protein extraction reagent (M-PER) (Thermoscientific Pierce, 
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Rockford, IL, USA) halt protease inhibitor (Thermoscientific Pierce) and 1 mM phenylmethylsulfonyl 
fluoride (PMSF) (Thermoscientific Pierce). A Bradford dye-binding method (Bio-Rad, Hemel 
Hempstead, Hertfordshire, UK) was used for normalisation. Total MMP-13 levels were analysed by 
quantitative sandwich ELISA technique (Cusabio, Wuhan, Hubei Province, China) according to the 
manufacturer’s instructions and absorbance measured at 450 nm with the correction wavelength set at 570 
nm. Results were calculated from a standard curve. Three independent experiments (n=3) were performed 
in triplicate for each experimental concentration and time interval. 
 
MMP-13 Enzyme Activity Assay. The specificity of the MMP-13 inhibitor was determined by addition of 
0 (control), 0.5, 1, 2, 5 and 10 µM MMP-13i to samples containing 100 ng/ml of recombinant MMP-9 
and MMP-13, which was diluted in assay buffer to a final dilution ratio of 1:100 (AnaSpec, San Jose, 
CA). A 96-well plate format was used with the Sensolyte™ 490 MMP-13 fluorimetric assay kit as per the 
manufacturer’s instructions (Anaspec). Zymogens or pro-MMP-9 and 13 were activated immediately 
prior to experimentation by incubation with 1 mM 4-aminopheylmercuric acetate (APMA) for 40 mins 
(MMP-13) and 1 hour (MMP-9) at 37°C. Diluted samples were incubated for 45 minutes in a black 96-
well plate (Perkin Elmer, Waltham, MA, USA) prior to the fluorescent intensity being measured by a 
spectrophotometer (Tecan Genios Spectrophotometer) at 360 nM (excitation) and 465 nM (emission).  
To measure MMP-13 activity in DPCs, cultures were seeded (6 x 10
4
 cells per well) in a 6-well 
culture plate. At 72 h (experimental day 0), the cells were cultured for 24 h in supplemented mineralizing 
medium either containing 1 µM SAHA or 2 µM MMP-13i or a combination of both. Active MMP-13 
activity was analysed at 2 time-points (48 h and 14 days) to reflect an early and late time point to coincide 
with the gene expression data. In the 48 h group and 14 day group, the HDACi-supplemented 
mineralizing medium was removed after 24 h prior to culture with an SAHA-free mineralizing medium 
for further 24 h or 13 days. In the MMP-13i samples the inhibitor supplemented the culture for the 
duration of the experiment. Two control groups consisting of supplemented α-MEM and supplemented 
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mineralizing medium. At the designated time-point, the medium was aspirated and the cell monolayer 
gently washed twice in ice cold PBS (pH 7.4), prior to the addition of 300 µl lysis buffer containing M-
PER (Thermoscientific Pierce), halt protease inhibitor (Thermoscientific Pierce) and 1 mM PMSF 
(Thermoscientific Pierce). Harvested cells were collected. The Bradbury dye-binding method (Bio-Rad, 
Hemel Hempstead, Hertfordshire, UK) was used to equalize total protein concentrations in samples.  
A 96-well plate format was used as before with the Sensolyte™ 490 MMP-13 fluorimetric assay 
kit according to the manufacturer’s instructions (Anaspec). Briefly, the pro-MMP-13 zymogen was 
activated immediately prior to experimentation in all samples by incubation with 1 mM APMA for 40 
mins at 37°C.  Fluorescent intensity was measured by a spectrophotometer (Tecan Genios 
Spectrophotometer) at 360 nM (excitation) and 465 nM (emission). For calculation of MMP-13 activity, 
each measurement was background-corrected to the average of the substrate controls. As the FRET 
substrate in the  Sensolyte™ 490 MMP-13 kit can also be cleaved by MMP-1, -2, -3, -8, and -12 the 
MMP-13 specific inhibitor group was used to ascertain the effect of MMP-13 alone. Three independent 
experiments (n=3) were performed in triplicate for each experimental concentration at both time intervals. 
 
Chemotaxis Transwell assay. To measure vertical DPC migration, 30 µl of supplemented α-MEM 
(without FBS) or control solutions were added into wells of a 96-well micro-chemotaxis plate with a 8 
µm-pore size (NeuroProbe, Receptor Technologies, Warwick, UK) [43]. DPCs (3x10
4
) were seeded in 
wells of the upper chamber. Test solutions examined supplemented α-MEM (without FBS) containing 1 
and 3 µM SAHA, 1 and 2 µM MMP-13i and both 1 µm SAHA and 2 µM MMP-13i.  DPCs in the SAHA 
test solutions were exposed to SAHA in culture for 3 h prior to seeding in the assay chamber. Control 
solutions included a negative control of supplemented α-MEM (without FBS) and a positive control of α-
MEM medium containing 10% FCS. The micro-chemotaxis plate was incubated at 37°C in 5% CO2 in air 
for 3 h to allow cell migration. Centrifugation was used to collect cells from the under-surface of the filter 
from the pores onto the bottom of the 96-well plate and 1mg/ml calcein AM (Life Technologies, Dun 
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Laoghaire, Ireland) was added to each well at a final dilution ratio of 1:250 for 30 minutes to label cells 
prior to fluorescence measurement with a spectrophotometer (Tecan Genios Spectrophotometer) at 
excitation 486 nM and emission of 540 nM. Readings were converted to cell numbers using standard 
curves of known cell numbers (Smith et al., 2012).  Three independent experiments (n=3) were performed 
in triplicate for each experimental group. 
 
Scratch wound healing assay. To assess horizontal migration, DPCs were seeded at a density of 6 x 10
4
 in 
6-well plates and cultured in supplemented α-MEM until confluent. Cells were starved for 24 h in 
supplemented α-MEM medium without FBS, prior to a carefully placed scratch wound being made 
through the confluent monolayer using light pressure and a 200µl pipette tip (0 h). DPCs were washed 
with PBS to remove cell debris and incubated with mineralizing medium in the presence and absence of 1 
µM SAHA and 2µM MMP-13i for 24 h. At 0 h and 24 h, images of the scratched monolayer cultures 
were captured (Primovert, Carl Zeiss, Cambridge, UK). Data were quantified by measuring each wound 
closure area using ImageJ software (ImageJ, USA) and expressing as a percentage relative to the wound 
closure area in the control medium. Three independent experiments (n=3) were performed in triplicate for 
each experimental group. 
 
Statistical Analyses. One-way analysis of variance (ANOVA) and Tukey’s post-hoc tests were used for 
experiments to determine the influence of HDACi and MMP-13i concentration (p<0.05) on the cells 
using SigmaStat 14.0 software (SPSS, IL, USA). The statistical significance of the qRT-PCR data was 
assessed using Student’s t-test. Microarray gene expression and pathway analysis were assessed as 
previously described. 
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Results 
Short-term SAHA treatment promotes mineralization without loss of cell viability, while long-term SAHA 
inhibits differentiation. Previous dental pulp cell experimentation has shown that pan-HDACi 
(Trichostatin A and Valproic acid) can exert anti-proliferative effects at relative high concentrations, but 
at relatively low concentrations can promote mineralization dose-dependently (Duncan et al., 2012; 
Duncan et al., 2013). To investigate the cellular effects of SAHA (Grant et al., 2007), the effects of low 
doses of SAHA on primary DPC growth, viability, apoptosis and mineralization were investigated. While 
DPC numbers were decreased (reduced up to 45%) at 24 h by the higher experimental concentrations of 3 
and 5 µM SAHA (p=0.012/p<0.001), compared with HDACi-free control cultures, at a SAHA 
concentration of 1 µM there was no significant effect on growth (Fig. 1A). Furthermore, cell viability 
investigated by both Trypan blue exclusion and live/dead staining demonstrated no significant loss of 
viability at 24 h (p>0.140/ p>0.275) at the low dose SAHA concentrations applied. A relatively small 
(~10%) but significant loss of viability at 5 µM SAHA was demonstrated by live/dead staining compared 
with the control at 48 h (p=0.003) (Fig. 1B). Consistent with previous HDACi experimentation (Duncan 
et al., 2013), 14 d mineralizing cultures exposed to an initial 24 h dose of SAHA, demonstrated 
significant dose-dependent increases in mineralization per cell at all concentrations >0.5 µM (p<0.046) 
applied, compared with HDACi-free control cultures (Fig. 1C). Notably, samples in which the HDACi 
was replenished every 3 days for the duration of the 14 d mineralization experiment demonstrated the 
opposite effect, with mineralization per cell inhibited at all concentrations >0.5 µM SAHA (p<0.013). 
This finding is supported by a recent in vivo animal study, which reported that the HDACi dosage regime 
may be as critical in promoting a positive mineralization response (Xu et al., 2013). From the growth, 
viability and mineralization data, 1 µM SAHA was selected for further flow cytometry (FC) and gene 
expression analysis as it was the highest mineralization promoting concentration not to induce DPC 
growth arrest at 24 h. Viable cell numbers data assessed by FC (Fig. 1D) were not significantly affected at 
1 µM SAHA (p=0.058), while no significant increase in early or late apoptosis was detected following 24 
h SAHA exposure (Fig. 1E-F). 
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SAHA significantly altered DPC gene expression at relatively early and late mineralization inducing 
time-points. To determine the molecular mechanisms whereby 1 µM SAHA accelerates mineralization 
effects, we performed microarray analyses. Based on previous work (Duncan et al., 2013), we 
hypothesized that 24 h SAHA treatment would reprogram gene expression at a relatively early time-point 
and accelerate the differentiation process up to 14 days. Subsequently, we isolated mRNA from primary 
DPCs cultured in mineralizing medium at 24 h, the end of SAHA exposure, and 14 d. At 24 h, of the 
23,347 genes analysed, SAHA significantly increased the expression >2-fold of 314 transcripts and 
suppressed the expression of 450 genes, representing alteration of only 3.3% of the array 
oligonucleotides, while only 23 transcripts were similarly up-regulated and 13 down-regulated at 14 d 
(Fig. 2A and 2B). The top 40 SAHA most up- and down-regulated genes at 24 h are listed in Tables 2 & 3 
and the top 20 up- and down-regulated genes at 14 d in Tables 4 & 5. The observed gene expression 
patterns demonstrate that although SAHA-induced transcriptional change, more genes were suppressed 
than induced at 24 h and the expression changes were of a relatively modest level. Notably, similar levels 
of differential gene expression have been reported in other HDACi high-throughput transcriptomic studies 
(Schroeder et al., 2007; Boudadi et al., 2013). Interestingly, although selected mineralization-associated 
transcripts are significantly upregulated only at 24 h (MMP-9, 2.99-fold; Adrenomdeullin, 3.4-fold), 
Ameloblastin was upregulated at 14 days only (1.72-fold) and MMP-13 at both time points (2.45-fold 24 
h; 1.6-fold 14 d) (Fig. 2C).  
 
SAHA-induced genes within the matrix metalloproteinase family and endochondral ossification related 
pathway in DPC s. To identify potential pathways that are affected by SAHA exposure in primary DPCs 
under mineralizing conditions, the microarray gene expression dataset was subjected to pathway analysis 
using Go-Elite and Pathvisio analysis software. Bioinformatic analysis indicated that the endochondral 
ossification pathway and the matrix metalloproteinase family (Fig. 2D) were significantly induced by 
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SAHA exposure in DPCs at 24 h (Table 6). Specifically, four up-regulated genes (MMP-9, 2.99-fold; 
MMP-13 2.45-fold; Ctsl1, 2.24-fold; Plat, 1.93-fold) playing critical roles in removal and organisation of 
extracellular matrix were identified. From this select group of genes, MMP-13 was of particular interest 
as it was previously reported that the Class II HDAC-4 repressed MMP-13 transcription in a mineralizing 
cell-line (Shimizu et al., 2010). Furthermore a potential role for MMP-13 in human pulp cell 
differentiation has been proposed (Suri et al., 2008; Yoshioka et al., 2013). As a result, a panel of 20 
genes of interest, including MMP-13 and MMP-9, were selected for confirmatory qRT-PCR analysis 
(Table 1). A range of transcripts was selected based on their levels of differential regulation, their 
potential roles in mineralization processes and pathways (e.g endochondral ossification). The 
confirmatory analysis corroborated the microarray data (Table 7). Notably, at 24 h, SAHA-induced 
significant increases in MMP-9 (2.76-fold, p=0.011), MMP-13 (2.19-fold, p=0.043), as well as expression 
of several up-regulated mineralization genes which have been reported as significant markers of dental 
pulp mineralization, including Nestin (1.82-fold, p=0.005), IBSP (2.38-fold, p=0.005), BMP-4 (2.79-fold, 
p=0.015) and Adrenomedullin (3.06-fold, p=0.047) (Fig. 3A and 3B).  
 
MMP-13 protein expression and enzyme activity are increased in mineralizing DPC cultures and further 
increased by low-dose SAHA. To further analyse the interaction of SAHA and MMP-13, DPCs were 
cultured under mineralizing conditions in the presence and absence of SAHA for 24 h, prior to HDACi-
free incubation for up to 21 days. The aim of this time-course assay was to examine the expression and 
activity of MMP-13 protein during DPC proliferation, differentiation, and mineralization; it has 
previously been shown (Winchester et al., 1999; Suri et al., 2008) that MMP-13 expression increases 
during the DPC differentiation before reducing later during mineralization. The influence of HDACi on 
MMP-13 expression over the same time period has not been previously investigated. Overall in this study, 
MMP-13 protein expression, measured by quantitative ELISA, demonstrated a peak level at 7 days in all 
groups (supplemented medium, mineralizing medium, mineralizing medium/SAHA), which reduced at 14 
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days and returned at 21 days to baseline levels. Although there were no significant differences in MMP-
13 protein levels at 24 h (p>0.728) in any group, by 7 days a significant increase was evident in 
mineralizing cultures in the absence (p=0.044) and presence of 1 µM SAHA (p=0.02), compared with 
non-mineralizing control cultures (Fig. 4A). The addition of SAHA to mineralizing cultures resulted in a 
significant increase in MMP-13 expression at 7 days compared with the mineralizing medium control 
(p=0.034). At 14 days, there was also a significant increase in the expression of MMP-13 protein levels 
for the SAHA samples, compared with both the supplemented medium group (p=0.03) and the 
mineralizing medium group (p=0.029).  At the late mineralization stage of 21 days, there were no 
significant differences between any groups and MMP-13 expression returned to baseline levels.   
To determine whether changes in active MMP-13 enzyme activity reflected increased gene and 
protein expression, we used a commercial fluorogenic activity assay and selective pharmacological 
inhibition to block MMP-13 activity. Experimental MMP-13i concentrations were established initially by 
reference to previously published studies (Toriseva et al., 2007; Nishimura et al., 2012; Lei et al., 2013). 
An in vitro experiment was also undertaken to confirm enzyme activity inhibition and specificity. MMP-
13i resulted in an 87% reduction of MMP-13 activity at a concentration of 1 µM and 93% reduction at 2 
µM (Fig. 4B), however, for all inhibitor concentrations >0.5 µM, activity was significantly reduced 
(p<0.0001). At the same concentrations the MMP-13i had no significant effect on MMP-9 activity 
(p=0.709) (Fig. 4B). Subsequently, a fluorogenic activity assay was utilized to assess MMP-13 activity in 
DPCs cultured in supplemented medium, mineralizing medium and SAHA-augmented mineralizing 
medium. The selected times for analysis (48 h, 14 d) were similar to microarray gene expression data, 
however, 48 h samples were more discriminative than 24 h, at which there no increase in enzyme activity 
(data not shown); a finding supported by previous experimentation (Lei et al., 2013). MMP-13 activity 
significantly increased in the extracts of DPC cell pellets at both 48 h and 14 days, both in the presence of 
mineralizing medium (48 h, p=0.009; 14 d p<0.0001) and mineralizing medium + SAHA (48 h, 
p<0.0001; 14 d p<0.0001) compared with a supplemented control (Fig. 4C/D), confirming that MMP-13 
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activity as well as protein expression was increased in mineralizing cultures. When comparing only the 
groups cultured in mineralizing conditions, the addition of SAHA significantly increased activity over 
HDACi-free cultures at 48 h (p=0.042) and 14 days (p=0.041), supporting the transcriptomic and ELISA 
data. The addition of a specific MMP-13i reduced enzyme activity compared with inhibitor-free 
mineralizing cultures, but not significantly at 48 h (p=0.09) (Fig. 4C) and 14 days (p=0.131) (Fig. 4D). 
Notably, a significant reduction in MMP-13 activity was evident when a MMP-13i was added to the 
SAHA mineralizing cultures at both 48 h (p=0.048) and 14 days (p=0.001). Interestingly, the addition of a 
MMP-13i reduced the enzyme activity to levels below that of the mineralizing culture controls. 
 
MMP-13 inhibition promotes mineralization in dental pulp cells in both the presence and absence of 
SAHA at concentrations not reducing cell growth or viability. As previous data demonstrated that 1 µM 
SAHA increased both mineralization and mineralization-associated transcript levels, we hypothesised that 
specific inhibition of MMP-13 would inhibit DPC mineralization. To investigate the mineralizing effect 
of MMP-13, a repeat of the previous 14 day SAHA mineralization experiment in the presence or absence 
of a selective MMP-13i was performed. The MMP-13i concentrations selected (1 and 2 µM) were chosen 
based both on the previous results of the enzyme activity assays and a cell growth assay which 
demonstrated that DPC growth was only significantly inhibited (reduced by 15%) at 24 h in the samples 
containing a combination of 1 µM SAHA and 2 µM MMP-13i (p=0.01), compared with HDACi-free 
mineralizing control cultures (Fig. 5A). Other groups containing SAHA alone or in combination with 1 
µM MMP-13i demonstrated no significant effect on growth (p>0.128).  At 5 days, the results differed 
with significant growth inhibition evident for all three HDACi-containing cultures, SAHA alone 
(p=0.005), SAHA + 1 µM MMP-13i (p=0.002) and SAHA + 2 µM MMP-13i (p=0.004) compared with 
mineralizing control cultures. Notably, in the absence of SAHA both 1 and 2 µM MMP-13i did not 
significantly inhibit DPC growth (p>0.974). DPC viability, assessed by Trypan blue exclusion, was not 
significantly affected by any of the concentrations of MMP-13i used in this study (results not shown). As 
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the MMP-13i was not shown to affect growth or viability, both concentrations were investigated in a 
mineralization assay in the presence and absence of 1 µM SAHA. 
In both the presence and absence of SAHA, MMP-13 inhibition increased matrix mineralization 
dose-dependently (Fig. 5B), with significant increases in mineralization evident in the SAHA-free group 
with 2 µM MMP-13i (p=0.12) and in the SAHA group in combination with 1 and 2 µM MMP-13i (p=-
0.016/p=0.001), respectively.  As a dose-dependent MMP-13i-induced mineralization response in DPCs 
was observed with Alizarin red staining, further analysis of differentiation was assessed by analysis of 
gene expression for several mineralization-associated transcripts (Fig. 5Ci-v). The transcripts were 
selected based on the results of this studies validatory RT-PCR, with a focus on HDACi-induced genes 
demonstrated to have a role in the dental pulp mineralisation process; BMP-4 (Duncan et al., 2012), 
Adrenomedullin (Musson et al., 2010), Osteopontin (Duncan et al., 2013), MMP-9 (Wu et al., 2015) and 
IBSP (Gopinathan et al., 2013). At 24 h MMP-13 inhibition significantly increased IBSP (p=0.003) and 
MMP-9 (p=0.014) transcript levels, while at 5 days IBSP (p=0.035), ADM (p=0.036) and Osteopontin 
(p=0.011) levels were increased compared with the mineralizing medium control (Fig. 5Ci-v). 
Furthermore, combinations of SAHA and MMP-13i in culture also significantly increased expression of 
BMP-4 (p=0.041), IBSP (p=0.048), ADM (p=0.002), Osteopontin (p=0.015) and MMP-9 (p=0.014) at 24 
h and BMP-4 (p=0.001), IBSP (p=0.002), ADM (p=0.013), Osteopontin (p=0.002) and MMP-9 (p=0.003) 
at 5 days compared with the mineralizing medium control.  
 
MMP-13 specific inhibition suppresses SAHA-enhanced dental pulp cell migration. Wound healing in the 
damaged dental pulp involves the migration of progenitor cells to the site of injury (Yoshiba et al., 1996). 
HDACis, including SAHA, have previously been shown to increase migration in various cell types (Lin et 
al., 2012), while MMP-13 is known to regulate cell migration through its action on cell phenotype (Lei et 
al., 2013). Subsequently, we hypothesised that two low concentrations of HDACi (1, 3 µM) would 
stimulate migration of DPCs in a transwell migration assay and that inhibition of MMP-13 activity may 
reduce this effect. Using transwell migration and wound healing scratch assay, primary DPC migration 
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was investigated in vitro following 3 h SAHA treatment. The transwell assay demonstrated a significant 
increase in primary DPC migration of 24% and 38% in the presence of 1 µM (p=0.007) and 3 µM 
(p<0.001) SAHA, respectively, compared with the negative control (Fig. 6A). No significant increase in 
cell migration compared with the control was evident after the addition of 1 µM (p=0.157) or 2 µM 
(p=0.253) MMP-13i in the absence of SAHA. The combination of 2 µM MMP-13i and 1 µM SAHA 
significantly suppressed the SAHA-induced migration (p=0.013). These data indicate that MMP-13 
expression may be partly responsible for the enhanced cell migratory effects demonstrated. These results 
were further corroborated by the wound healing ‘scratch’ assay in DPC monolayers (Fig. 6B), which 
demonstrated significantly enhanced DPC migration in the presence of 1 µM SAHA (p=0.049) compared 
with the control, while notably the addition of 2 µM MMP-13i (p=0.999) alone or in combination with 1 
µM SAHA (p=0.945) had no significant effect on wound healing (Fig. 6C-D). 
 
Discussion 
Dental pulp tissue has the ability to repair by the migration of a progenitor cell population to the 
injury site and their differentiation into odontoblast-like cells by the defensive process of reparative 
dentinogenesis (Smith et al., 2008). Dentistry exploits these regenerative capabilities clinically using a 
range of restorative procedures, however, there is a need to improve the clinical success of these 
treatments and develop novel pulp regenerative tissue engineering strategies (Murray et al., 2007). 
Several in vitro studies have indicated that HDACis offer the potential to promote regenerative processes 
by increasing differentiation of dental pulp cell populations (Duncan et al., 2011; Duncan et al., 2012; Jin 
et al., 2013; Paino et al., 2014). In this study, we for the first time characterised epigenetically-modified 
gene expression events that occur in SAHA-treated DPCs, identifying up-regulated pathways and key 
mediators. Our novel data indicates that SAHA modulates pulpal MMP expression, specifically 
increasing the activity of MMP-13, which is partly responsible for modulating mineralization and DPC 
migratory events. 
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Previous DPC experimentation using different HDACi (VPA, TSA) demonstrated acceleration of 
matrix mineralization (Duncan et al., 2013; Jin et al., 2013; Paino et al., 2014) and in the present study, 
the initial hypothesis that SAHA did not induce significant anti-proliferative, apoptotic or necrotic effects, 
but could stimulate in vitro mineralization was confirmed. The importance of the HDACi-concentration 
on mineralization is also highlighted, with the observed dose-dependent increase consistent with previous 
studies utilising osteoblast (Cho et al., 2005), dental-papilla derived cell lines (Duncan et al., 2012; Kwon 
et al., 2012) and primary DPCs (Duncan et al., 2013). As HDACi-induced mineralization was accelerated 
over a relatively narrow range of low SAHA concentrations, it is critical that optimal concentration 
parameters are established for each individual HDACi. Supporting previous results using VPA and TSA 
(Duncan et al., 2012), SAHA induced mineralization (>2-fold increase) in cultures supplemented with 24 
h SAHA, prior to HDACi-free culture for the remainder of the 14 day experiment. Notably, extension of 
the SAHA supplementation (14 days, changed every 3 days) inhibited mineralization deposition and 
highlighting the critical importance of HDACi-treatment duration. This finding could help explain the 
paradoxical findings that HDACis stimulate osteogenic mineralization in vitro (Sakata et al., 2004; Cho et 
al., 2005; Schroeder and Westendorf, 2005; De Boer et al., 2006), but long-term in vivo oral VPA 
administration in humans (Nissen-Meyer et al., 2007), or 3-4 week systemic administration in mice 
(McGee-Lawrence et al., 2011) results in overall bone loss. It was previously proposed that the bone loss 
was due to a reduction in immature osteoblast numbers in vivo, while in vitro mature osteoblast 
populations were resistant to the detrimental effects of HDACi (McGee-Lawrence and Westendorf, 
2011), however, it was recently demonstrated in mice that reducing the frequency of in vivo SAHA 
administration (from daily to every 3 days) resulted in no animal weight loss or cell toxicity (Xu et al., 
2013). Our results highlight that limiting the HDACi-exposure, as well as establishing optimal 
concentration levels, is critical to avoid possible the HDACi-induced mesenchymal stem cell toxicity 
referred to in previous studies (Xu et al., 2013). 
Despite recent advances, the mechanisms driving dentine matrix mineralization and HDACi-
induced promotion of pulp cell mineralization remain to be elucidated. This study clearly demonstrates 
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the SAHA induced differential expression of several novel genes in primary rat DPCs cultured under 
mineralizing conditions at early (24 h) and later time points (14 d). Furthermore, the involvement of many 
of the identified transcripts has not previously been identified in HDACi microarray studies (Tables 2-5). 
The observed differences are likely to be attributable to the cell type (i.e. rat primary DPCs have not 
previously been studied in this context), the mineralizing conditions and the relatively short duration of 
SAHA exposure (24 h). Similarly to previous HDACi high-throughput array studies, genes were both 
induced and suppressed by SAHA (LaBonte et al. 2009; Dudakovic et al., 2013), however, notably at 24 
h more genes were suppressed, highlighting tissue-dependent differences in HDACi-induced effects. Only 
a relatively small number (3.3%) of SAHA induced genes showed a significant >2.0-fold transcriptional 
change at 24 h, which reduced to 0.15% at 14 days, demonstrating that 24 h SAHA-induced effects are 
generally reversible and do not persist through to the mineralization stage (Fig. 2A). The labile nature of 
histone tail acetylation has been shown in other recent microarray studies in non-mineralizing cultures 
(Boudadi et al., 2013), but may also be a particular feature of the binding characteristics of the particular 
HDACi (Lauffer et al., 2013). SAHA and other hydroxamate-containing HDACi have been described as 
having short-residence times compared with other benzamide-containing inhibitors (Lauffer et al., 2013). 
By logical extrapolation, it is therefore to be expected that various HDACis are likely to differentially 
affect the expression of different genes due to variations in potencies, binding characteristics and 
specificities (Schroeder et al., 2007; Khan et al., 2008; Lauffer et al., 2013. However, SAHA was selected 
for this study due to its FDA clinical approval (SAHA=voronostat, Zolinza™), frequent experimental use 
and positive mineralization-inducing action compared with other HDACis (Kwon et al., 2012). Indeed, 
comparison of our data with the nearest equivalent set of osteogenic gene array data (Schroeder et al., 
2007), shows a similar pattern of expression, despite differences in cell type (preosteoblasts vs primary 
DPCs), treatment time (18 h vs 24 hr) and HDACi (TSA, MS-275 vs SAHA). Notably, several genes 
identified as potentially responsible for osteoblast maturation (Schroeder et al., 2007) were also 
upregulated in the current study, such as the apical membrane phosphoprotein, Slc9a3r1 (Fig. 2C) and  
glutathione S-transferase alpha 4 (Table 2), while other common cell cycle genes were down-regulated 
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including Cyclin A1, Cyclin B2 and Polo-like kinase 1 and 4 (Table 3). Indeed, if a range of HDACi-
specific gene array studies are compared there is significant overlap in the differentially expressed genes 
identified (see final column in Tables 2-5). The SAHA induced down-regulation of cell cycle associated-
genes (Cyclin A1, B2) was supported by reduced DPC growth at 5 days (Fig. 5A), while, DPC 
mineralization was increased concomitantly (Figs 1C & 5B); supporting a theory that SAHA reduced the 
proliferation of DPCs, while promoting cell differentiation.  
Gene expression microarray, pathway and qRT-PCR analyses identified the up-regulation of 
several members of the MMP family (notably MMP-9, MMP-13) (Fig. 2D) as well as other key genes 
responsible for degradation of extracellular matrix, such as Ctsl-1 and Plat and other tissue proteases, 
including ADAMTS 9 and 5. It has recently been noted in vivo that tissue inhibitor of matrix 
metalloproteinase 1, (TIMP-1), MMP-3 and MMP-13 expression can be upregulated in DPCs in vivo 3 
days after cavity preparation in rodent teeth and the authors highlighted a potential role in pulp repair 
(Yoshioka et al., 2013). In our study, although MMP-3 expression was not increased by HDACi, TIMP-1 
gene expression was increased at 24h by SAHA (1.6-fold at 24 h). Furthermore, our pathway and gene 
expression analysis (both microarray and RT-PCR) indicated that 1 µM SAHA up-regulated the 
expression of MMP-13 and a range of other proteolytic signalling molecules (Fig. 2D). The expression of 
a range of MMPs has previously been demonstrated to be induced by HDACi in various cell types (Mayo 
et al, 2003; Schroeder et al., 2007 Lin et al., 2012), but not specifically linked to modulation of the 
mineralization process. In addition, it was previously reported that HDAC-4 repressed MMP-13 gene 
expression in bone (Shimizu et al., 2010) and in a subsequent studies, that parathyroid activation of 
MMP-13 transcription required HAT activity (Lee and Partridge, 2010) and was negatively regulated by 
SIRT-1 (Fei et al., 2015), highlighting an interaction between HDACs/HAT, mineralization and MMP-13. 
While it is accepted that other MMP members may have important roles (e.g. MMP-9, MMP-2) in 
mineralization, previous findings prompted us to examine the interaction between SAHA and MMP-13 in 
order to characterise an as yet unidentified role for MMP-13 in pulp matrix mineralization. We show here 
that MMP-13 protein expression is increased in mineralizing DPCs and further increased in the presence 
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of SAHA. Furthermore, after the addition of a selective MMP-13 antagonist, there was increased 
expression of several mineralization-associated genes (BMP-4, IBSP), as well as MMP-13 enzyme 
activity at early and late time-points. This highlights a central role for MMP-13 in modulating 
mineralization processes in the pulp supporting a previous proposal (Suri et al., 2008).  
A possible explanation for this less straightforward observation is that MMP-13 inhibition 
increased matrix calcification in mineralizing cultures in the presence or absence of SAHA. MMP-13 
expression has been linked to the promotion of regenerative responses (Toriseva et al., 2007) and 
differentiation (Lei et al., 2013) in certain cell types, however, it has been reported in other tissues that 
MMP-13 inhibition can stimulate increased differentiation (Wu et al., 2002b; Nishimura et al., 2012).  
Within this and other studies (Winchester et al., 1999; Suri et al., 2008), MMP-13 protein expression was 
increased in mineralizing cultures and here we showed a further increase in the presence of SAHA. 
Logically, it might have been expected that inhibiting a collagenase, such as MMP-13, would reduce 
matrix mineralization, however, paradoxically mineralization was increased with selective MMP-13 
inhibition. It can be speculated that this may result from a feedback mechanism in which MMP-13 
expression facilitates an ordered deposition of mineral, thus preventing the formation of excessive or low 
quality mineral (Staines et al., 2014). This theory is supported by the results of MMP-13 knockout mice 
experimentation in which ossification is delayed and collagen accumulates in growth plate regions 
(Yamagiwa et al., 1999; Inada et al., 2004), as well as an impaired bone healing and remodelling after 
fracture (Behonick et al., 2007). Additionally, it is likely that tissue proteases, including MMP-13, have 
broader reparative roles in the pulp cleaving bioactive growth factors or releasing dentine matrix proteins 
from the matrix to stimulate cell migration and promote differentiation (Ortega et al., 2003) (Fig. 7). In 
this study, the promotion of mineralization processes by HDAC and MMP-13 inhibitors is supported by 
RT-PCR, as mineralization-associated gene expression was enhanced at two time-points, including a 
further increase in MMP-9 expression, a transcript identified by gene expression analysis as being 
significantly upregulated by SAHA alone at 24 h. Although not specifically investigated in this study, it 
has been previously demonstrated by others that MMPs and their inhibitors may form part of an intricate 
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network of support, feedback and synergy; regulating the activity of other MMPs (Ortega et al., 2003). 
Indeed, MMP-9 and MMP-13 have been previously reported to act synergistically in their effects on bone 
remodelling and development (Engsig et al., 2000) and may act similarly within dental pulp tissue. 
Dental pulp healing after injury has classically been described as a two-stage process (Schröder, 
1985), initially involving vascular and defence cell proliferation, migration and adhesion aiming to 
eliminate the injurious microbial irritant. Thereafter, wound repair proceeds with proliferation, migration 
and adhesion of various cells including progenitor or stem cells, which will differentiate under the 
influence of various bioactive molecules to odontoblast-like cells to produce reparative tertiary dentine 
(Smith et al., 1995; Smith et al., 2002; Smith et al., 2008). Cancer studies investigating neoplastic cell 
migration have demonstrated that even at low concentrations, a range of HDACi can increase cell 
migration; this finding was attributed to the epigenetic activation of gene transcription, tumour-
progressive genes and a change in cell phenotype in HDACi treated cells (Lin et al., 2012). 
Mechanistically, HDACi-enhanced cell migration has been shown to activate a range of transcripts 
including chemokine receptors, integrins, glycodelin, and the serine protease urokinase plasminogen 
activator (UPA) (Lin et al., 2005; Mori et al., 2005; Uchida et al., 2007; Pulukuri et al., 2007). Within the 
current study, at 24 h UPA was not significantly increased in expression, however, other studies have 
reported that MMPs released from tumour cells are crucial not only for tissue degradation in vivo, but also 
cell migration observed in vitro (Liotta et al., 1980; Laurenzana et al., 2013). Interestingly, it appears that 
in regenerating tissues MMP-13 activity is central to cell migration, playing an important role in skeletal 
muscle repair and myoblast migration (Lei et al., 2013), and cutaneous wound healing (Wu et al., 2002a; 
Hattori et al., 2009). In addition, pathological expression of MMP-13 has been attributed to increased 
growth and metastatic invasion capacity of squamous cell carcinoma in vivo (Ala-aho et al., 2004). 
However, HDAC inhibition demonstrates conflicting results with regard to cell migration with some 
studies reporting a significant increase in cell migration in vitro (Uchida et al., 2007; Spallotta et al., 
2013), while others reporting the opposite effect (Laurenzana et al., 2013). The rationale for these 
differences could be cell type-dependent, but this may also be a concentration effect with higher doses of 
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HDACis generally being shown to reduce cell migration (Uchida et al., 2007). Within the present study, 
low concentrations of SAHA dose-dependently increased DPC migration, in both cell monolayer and in 
transwell migration assays, an effect which was blocked by a selective MMP-13 inhibitor. Potentially, the 
HDACi-induced increase in MMP-13 expression could further enhance migration in vivo by promoting 
cleavage of growth factors or release of matrix proteins and increase chemotaxis (Ortega et al., 2003; 
Paiva and Granjeiro, 2014). DPC migration effects have translational relevance, as SAHA could be 
applied to the exposed pulp surface during vital pulp treatment; this could induce MMP-13 expression, 
potentially promoting the migration of dental progenitor cells from the centre of the pulp to the wound 
surface for differentiation into odontoblast-like cells during reparative dentinogenesis.  
HDACi have been shown to promote mineralization responses by the induction of a range of 
genes in osteoblast cultures (Schroeder et al., 2007).  Here we report that histone deacetylation promotes 
DPC mineralization and induces MMP-13 expression and activity at both early and late time-points, while 
MMP-13 also mediates a SAHA-induced increase in DPC migration. From a translational perspective the 
promotion of tissue-repair processes was evident after a 24 h dose of topical SAHA, highlighting the 
potential benefit of topical HDACi application to damaged dental pulps during regenerative vital pulp 
treatment. 
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Figure legends 
Fig. 1. Short-term SAHA application did not significantly reduce primary DPC proliferation, viability and 
apoptosis at low concentration, while mineralization was promoted dose-dependently. (A) SAHA 
supplemented DPC cultures for 24 h at a range of concentrations and cell numbers were ascertained by 
Trypan blue exclusion. The addition of SAHA significantly reduced primary cell growth at 3 and 5 µM, 
but not 1 µM. (B) The same SAHA concentrations as in (A) were analysed after 24 h and 48 h by a 
live/dead staining fluorogenic assay to analyse DPC viability and necrosis. Short-term SAHA 
supplementation (24 h, 48 h) significantly reduced cell viability only at higher (5 µM) SAHA 
concentrations after 48 h. (C) SAHA concentrations (0.25 - 5 µM) supplemented the mineralizing 
medium for 24 h or 14 days at the initiation of the experiment. The mineral production for SAHA is based 
on quantification of Alizarin Red S stain extracted from each experimental well and corresponding cell 
counts. Short-duration SAHA (24 h) accelerated mineralization per cell in DPCs dose-dependently at 14 
days, while prolonged SAHA exposure inhibits differentiation and prevents matrix calcification. (D) 
Effects of 1 µM SAHA on DPC apoptosis and viability in DPCs. FC images for control (no HDACi) (E) 
and 1 µM SAHA (F) after Annexin V-PI staining. Viable cells were observed in the left lower quadrant, 
early apoptotic cells in the right lower quadrant and late apoptotic cells in the right upper quadrant and 
charted as % total number of cells. A negative control (No SAHA) and a selected candidate concentration 
of 1 µM SAHA was investigated by FC at 24 h. All charted data are represented as mean ±SEM. For all 
experimentation, four independent experiments (n=4) were performed in triplicate for each HDACi 
concentrations. In the FC experimentation, 10,000 cell events were measured for each 
experimental/control group (n=4). Statistically significant differences (p<0.05) between the experimental 
and control are marked by an asterisk (*) or (**). 
 
Fig 2.  The effects of short-term low dose SAHA on relatively early and late stage gene expression under 
mineralizing conditions. (A) A time-course plot (1 day and 14 days) generated in GeneSpring GX12 
showing all altered genes (normalised intensity values) in the SAHA-supplemented DPC cultures 
compared with HDACi-free control cultures. Red lines indicate up-regulated genes and blue indicates 
down-regulated transcripts in the 24 h data. (B) Number of genes demonstrating >2 fold change after 
addition of SAHA. Heat maps showing gene expression along with a list of selected mineralization-
associated genes (C) and MMPs/TIMPs (D) expressed by DPCs at 24 h and 14 days in SAHA-
supplemented media compared with HDACi-free control cultures. All gene expression array experiments 
based on four biologically independent experiments (n=4). 
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Fig 3. Confirmatory gene expression using quantitative real-time-PCR. To validate microarray results, 
representative transcripts were quantified by qRT-PCR in untreated and SAHA-treated DPCs. (A) 
Selected up-regulated genes and (B) down-regulated genes at 24 h and (C) up- and down-regulated genes 
at 14 days expressed as fold increase over control. Error bars represent mean ± SEM of 4 independent 
experiments carried out in triplicate. Students t-test was used to ascertain statistical significance of 
experimental compared with control samples. 
 
Fig 4. The effects of SAHA on MMP-13 protein expression and enzyme activity. (A) Cell lysates from 
selected time points (1, 7, 14 and 21 days) were normalised using a Bradford dye-binding method and 
total MMP-13 protein levels quantified for each time point. MMP-13 production was analysed by ELISA. 
(B) A range of MMP-13i concentrations were added to samples of recombinant MMP-9, -13 and enzyme 
activity was measured fluorogenically for each inhibitor concentration. MMP-13 activity was blocked 
dose-dependently, but MMP-9 was not significantly altered. All experimental MMP-13i concentrations 
tested significantly decreased MMP-13 enzyme activity. (C/D) The effects of SAHA and a 
pharmacological MMP-13i on MMP-13 enzyme activity in mineralizing DPCs. DPCs were cultured in 
mineralizing medium ± SAHA/MMP-13i and compared with mineralizing and non-mineralizing control 
cultures at 48 h (C) and 14 days (D). MMP-13 activity (measured fluorogenically) increased in 
mineralizing culture and in the presence of SAHA at both experimental time-points. As the commercial 
FRET substrate was preferentially, but not exclusively cleaved by MMP-13, the selective MMP-13 
inhibition was used to analyse the role of MMP-13. Selective MMP-13 inhibition significantly reduced 
enzyme activity in the SAHA cultures.  Error bars represent SEM of three independent experiments 
carried out in triplicate. Significant difference p<0.05, denoted by asterix (*) between experimental group 
and normal medium control, symbol (^) between experimental group and mineralizing medium control 
and symbol (‡) between mineralizing medium + SAHA and mineralizing medium + SAHA + MMP-13i. 
 
Fig 5. The effects of a selective MMP-13i on primary DPC proliferation, mineralization and gene 
expression. (A) A selective MMP-13i supplemented SAHA and HDACi-free cultures for 24 h and 5 days 
at two concentrations (1 and 2 µM). Viable cell numbers ascertained by Trypan blue exclusion and cell 
counting. (B), In vitro calcification of DPCs under mineralizing conditions in the presence and absence of 
1 and 2 µM MMP-13i compared with SAHA supplemented and HDACi-free control groups. Alizarin red 
staining was used to demonstrate calcium deposits at 14 days and results presented as a fold increase in 
mineralization over the respective controls. (C) DPCs were cultured in mineralizing medium in the 
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presence or absence of 1 µM SAHA and 2 µM MMP-13i for 24 h and 5 days. mRNAs were isolated, 
reverse transcribed and amplified using real-time PCR with primers for (i) BMP-4, (ii) IBSP, (iii) 
Adrenomedullin, (iv) Osteopontin and (v) MMP-9 an compared to a supplemented mineralization control. 
The relative levels of mRNAs were normalized to β-actin and then expressed as fold stimulation over 
control. For all experiments, the error bars represent SEM of three independent experiments performed in 
triplicate. Asterix (*), p<0.05 and (**), p<0.005. 
 
Fig 6. The effects of SAHA and MMP-13 activity on dental pulp cell (DPC) migration. (A) Vertical 
migration of DPCs measured by transwell migration assay at 37°C for 3 h. Positive control (supplemented 
medium and 10% FCS), 1 µM and 3 µM SAHA had a statistically significantly greater effect on cell 
migration compared with the negative control. MMP-13i (1 and 2 µM) and SAHA in combination with 2 
µM MMP-13i was not significantly different compared with the negative control, indicating the MMP-13 
may be partly responsible for the migratory effects of DPCs). (B) Quantitative data from (C/D) showing 
cell migration in response to HDACis. (B) Horizontal migration of DPCs by wound healing scratch assay. 
The effect roles of 1 µm SAHA on the migration and motility of rat DPCs quantified from 24 hour scratch 
assay. Cells were treated with 1 µM SAHA for 24 h and a scratch made in the confluent cell monolayer. 
Images were obtained at 0 (Ci-iv) and 24 h post wounding (Di-iv). Values are mean ± SEM for 3 
independent experiments carried out in triplicate. Asterisks (*) show significant differences compared 
with control (p<0.05). Scale bars indicate 100 µm. 
 
Fig 7. Overview schematic illustration highlighting the potential roles of MMP-13 is reparative 
dentinogenesis. (A) HDACi (SAHA) applied topically to exposed damaged pulp tissue, accelerates 
mineralization processes (and the expression of a range of mineralization-associated transcripts) and 
increases expression of MMP-13 in pulp cells. The expression of MMP-13 is central to the control of 
mineralization processes and the activation of a range of bioactive molecules by cleavage. These 
molecules could potentially promote angiogenesis, mineralization and cell migration. Increased MMP-13 
expression has also been shown in inflamed dental DP cell lines (Zhang et al., 2013), which may have 
additional implications for dental pup healing. (B) Dental progenitor cells migrate from vasculature in 
central pulp under influence of bioactive molecules to injury site. Thereafter, the progenitor cells 
differentiate into odontoblast-like cells.  MMP-13 may directly influence this recruitment process by 
increasing cell migration or by cleavage of matrix-bound dentin matrix proteins to increase chemotaxis 
and differentiation. Additionally MMP-13 (and other MMP collagenases) will breakdown extracellular 
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matrix further increasing migration and stimulating repair. C, Fossilised dentine matrix proteins leach into 
the pulp as a result of caries (Smith et al., 2008) or restorative materials (Schröder, 1995; Tomson et al., 
2007) to promote reparative events. Growth factors released by MMP-cleavage (including MMP-13) 
further stimulate reparative response.   
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Table 1 Primer sequences used for primary rat pulp gene expression analyses  
 
 
 
Gene Primer sequence (5' → 3') Size 
bps 
NCBI Accession 
number 
β-Actin 
 
(F)-AGCCATGTACGTAGCCATCC 
(R)-ACCCTCATAGATGGGCACAG 
115 NM_031144 
Disabled homolog 1 (Drosophila)  
Dab1  
(F)- CCAGGTCAAGTCCACAGAGT 
(R)- TCAGGTTTTCGGGAGGGTAC 
106 NM_153621 
T-cell differentiation protein (Mal2) (F)- CTACGATGGTTGTGAAGCCG 
(R)- ACTGTCGGTTTCCAAGGAGT 
155 NM_198786 
RAS guanyl releasing protein 3 
(calcium and DAG-regulated) 
(Rasgrp3) 
(F)- CCTCTTGGTTCTGGCCTGTA 
(R)- GTCCAGGTCTCGGTGTCTAG 
 
148 NM_001108009 
Ameloblastin (Ambn) (F)-GAAAACCCGGCTCTCCTTTC 
(R)- ATTCAGGGGTGATCAGTGGG 
157 NM_012900 
Keratin 18 (Krt18) (F)- CTGGGGCCACTACTTCAAGA 
(R)- GCGGAGTCCATGAATGTCAC 
184 NM_053976 
Eph receptor A3 (Epha3) (F)- ATATGCTCCTCTCACTGCCC 
(R)- CGTGGGATGGGTAGGAGATC 
185 NM_031564 
Matrix metalloproteinase  13 
(Mmp13) 
(F)- AAGTGTGACCCAGCCCTATC 
(R)- GGGAAGTTCTGGCCAAAAGG 
147 NM_133530 
Matrix metalloproteinase  9 (Mmp9) (F)- AAACATGCTGAAACCGGACC 
(R)- GAGGGATCATCTCGGCTACC 
118 NM_031055 
Glutathione S-transferase alpha 4 
(Gsta4) 
(F)- ACAGCTGGAGTGGAGTTTGA 
(R)- GTGTCAGTAGCATCCCGTCT 
127 NM_001106840 
Rap2 interacting protein (Rap2ip) (F)- GCAGCATCGAGAACATGGAG 
(R)- TCTGGTAGTTCGGTTGTCCC 
131 NM_198758 
Tetraspanin 13 (Tspan13) (F)- CGGAGAGTATGCTGGAGAGG 
(R)- TTCTCGTCAAAGGAAAGCGC 
148 NM_001013244 
Adrenomedullin (Adm) (F)- ATGTTATTGGGTTCGCTCGC 
(R)- GGACGCTTGTAGTTCCCTCT 
123 NM_012715 
Spindle and kinetochore associated 
complex subunit 1 (Ska1) 
(F)- GGCCAGAGGAGGATCTTGAG 
(R)- TCCTGACCTTGTGCTTGCTA 
125 NM_001106134 
Minichromosome maintenance 
complex component 10 (Mcm10) 
(F)- GCATAACCTCCACTGGCATG 
(R)- ATTCCATCCCGTTCCCACTT 
135 NM_001107366 
Histone cluster 1, H1b (Hist1h1b) (F)- GTCTCCCGCCAAGAAGAAGA 
(R)-GCCAATGCCTTCTTCAGAGC 
147 NM_001109417 
Integrin-binding sialoprotein (IBSP) (F)- CAGTTATGGCACCACGACAG 
(R)- CATACTCAACCGTGCTGCTC 
116 NM_012587 
Transforming growth factor, beta 2 
(TGFβ2) 
(F)- TACCCGAGTCTAAGGTTGGC 
(R)-GGAAGGGACGAAGGACAGAA 
123 BC100663 
Bone morphogenic protein-4 (BMP-
4) 
(F)- CAAGCGTAGTCCCAAGCATC 
(R)- GGCCACGATCCAATCATTCC 
115 NM_012827 
 
Nestin 
 
(F)- CTGCAGAAGAGGACCTGGAA 
(R)- CATCCACAGACCCTAGCGAT 
129 NM_012987 
 
Osteopontin (spp1) 
 
(F)- CTGAAGCCTGACCCATCTCA 
(R)- TCGTCGTCATCATCGTCCAT 
143 NM_012881 
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Table 2 Top 40 known genes induced by SAHA in mineralizing rat DPC cultures at 24 h. References 
are for previous studies that reported up-regulation of the transcript or protein in cells or other cell 
systems by an HDACi (*). 
 
Gene Gene name Fold 
change 
t-test with 
Storey 
Up-regulation Reported 
Reference* 
Rap2 interacting protein  Rap2ip 8.9 2.13E-05  
Glutathione S-transferase alpha 4  Gsta4 8.2 2.65E-04 Schroeder et al., 2007 
Majumdar et al., 2012 
Tubulin, beta 2B class IIb  Tubb2b 7.9 0.00234 LaBonte et al.,  2009 
Monoacylglycerol O-acyltransferase 2 Mogat2 7.1 0.006320  
Brain expressed, X-linked 1  Bex1 7.0 6.39E-04 Foltz et al., 2006  
Fischer et al., 2007 
Phospholamban  Pln 6.3 2.94E-06  
Transmembrane protein 35 Tmem35 5.1 6.32E-05  
Coronin, actin binding protein 1A  Coro1a 5.0 3.37E-04 Moore et al., 2004 
Cell death-inducing DFFA-like effector a Cidea 4.8 1.96E-04  
Tetraspanin 13  Tspan13 4.8 4.12E-04  
Pentraxin 3, long Ptx3 4.6 0.01514  
Membrane-spanning 4-domains, subfamily A, member 14 Ms4a14 4.5 0.00328  
Kinesin family member C2  KIFC2 4.4 3.09E-04  
S100 calcium binding protein A1  S100a1 4.2 1.23E-04 Pryzbylkowski et al., 2008 
Disabled homolog 1 (Drosophila)  Dab1 4.1 0.01277 Noh et al., 2009 
Reticulon 1 Rtn1 4.1 4.72E-04 Fazi et al., 2009 
Cyclohydrolase I feedback regulator Gchfr 4.0 0.00414  
Angiopoietin-like 4  Angptl4 3.9 0.00126 Poulaki et al., 2009 
Secretogranin V  Scg5 3.8 0.00139 Bracker et al., 2009 
Integral membrane protein 2A  Itm2a 3.7 7.58E-04  
Alcohol dehydrogenase 1 (class I)  Adh1 3.7 7.58E-04  
Immunoglobulin superfamily, member 10  Igsf10 3.7 0.00171  
Adrenergic, beta-3-, receptor  Adrb3 3.6 0.00325  
GLI pathogenesis-related 1  Glipr1 3.6 3.49E-04  
Small nuclear ribonucleoprotein polypeptide N  Snrpn 3.6 0.01421 Suzuki et al., 2002 
Uroplakin 1B  Upk1b 3.5 0.00587 Milutinovic et al., 2007 
Chromobox homolog 7  Cbx7 3.4 0.00104  
Aldehyde oxidase 1  Aox1 3.4 8.74E-05  
Adrenomedullin Adm 3.4 1.45E-05 Poulaki et al., 2009 Majumdar 
et al., 2012 
CD302 molecule  Cd302 3.4 6.67E-04  
Brain expressed, X-linked 4 Bex4 3.3 0.00797  
Cholinergic receptor, muscarinic 4  Chrm4 3.3 7.30E-04 Ooi et al., 2006 
SATB homeobox 1  Satb1 3.2 0.00794  
Tctex1 domain containing 1  Tctex1d1 3.2 0.00136  
Sulfite oxidase  Suox 3.2 9.10E-06 Lee et al., 2004 
Cytochrome b-561  Cyb561 3.1 8.52E-04  
Ephrin1 Efna1 3.1 7.42E-05 Poulaki et al., 2009 
Sphingosine-1-phosphate receptor 1 S1pr1 3.1 3.96E-04 Nguyen-Tran et al., 2014 
Adrenergic, beta-2-, receptor, surface Adrb2 3.0 7.36E-04 Foltz et al., 2006 
Matrix metalloproteinase 9 Mmp9 3.0 4.46E-04 Mayo et al., 2003 
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Table 3 Top 40 known genes suppressed by SAHA in mineralizing rat DPC cultures at 24 h. 
References are for previous studies that reported down-regulation of the transcript or protein in cells 
or other cell systems by an HDACi (*).  
 
Gene Gene name Fold 
change 
t-test with 
Storey 
Down-regulation 
Reported Reference* 
Spindle and kinetochore associated complex subunit 1  Ska1 -97.2 1.12E-04  
Minichromosome maintenance complex component 10  Mcm10 -15.7 0.00957 Li and Li, 2008 
DDB1 and CUL4 associated factor 15 Dcaf15 -15.2 0.00924  
MIS18 kinetochore protein homolog A (S. pombe) Mis18a -11.4 0.00919  
Stathmin 1 Stmn1 -10.1 0.00301 Milli et al., 2008 
PDZ binding kinase  Pbk -9.3 6.57E-04  
Cyclin A2  Ccna2 -8.7 4.30E-04 Schroeder et al., 2007 
LaBonte et al., 2009, 
Majumdar et al., 2012 
Koutsounas et al., 2013 
Histone cluster 1, H1b  Hist1h1b -7.8 3.17E-04  
Cyclin B1  Ccnb1 -7.6 0.00323 Schroeder et al., 2007 
Kinesin family member 2C  Kif2c -7.4 5.37E-05 Dudakovic et al., 2013 
PHD finger protein 19 Phf19 -7.3 1.64E-04  
Antigen identified by monoclonal antibody Ki-67  Mki67 -7.1 2.43E-04 Majumdar et al., 2012  
Liu et al.,  2013 
Microtubule-associated, homolog (Xenopus laevis)  Tpx2 -6.7 0.00401  
Ribonucleotide reductase M2  Rrm2 -6.7 0.01415  
Polo-like kinase 1  Plk1 -6.7 0.00152 Lee et al., 2004 
Schroeder et al., 2007 
Polo-like kinase 4  Plk4 -6.7 0.01458 Schroeder et al.,  2007 
Suppressor APC domain containing 2  Sapcd2 -6.7 1.32E-04  
Urocortin 2 Ucn2 -6.5 0.00291  
Topoisomerase (DNA) II alpha  Top2a -6.3 0.00116  
Cell division cycle associated 3  Cdca3 -6.1 8.93E-04 Majumdar et al., 2012 
Protein regulator of cytokinesis 1  Prc1 -6.1 0.00235 Majumdar et al., 2012 
Ubiquitin-conjugating enzyme E2C Ube2c -6.1 0.00175  
IQ motif containing GTPase activating protein 3  Iqgap3 -6.0 0.01027  
Centromere protein F  Cenpf -6.0 0.00641  
Sperm associated antigen 5 Spag5 -5.9 7.62E-04  
Cell division cycle 20 homolog (S. cerevisiae)  Cdc20 -5.8 0.00454 Majumdar et al., 2012 
Microtubule associated serine/threonine kinase-like  Mastl -5.8 0.00195  
Kinesin family member C1  Kifc1 -5.7 1.38E-04  
Asp (abnormal spindle) homolog, microcephaly associated 
(Drosophila) 
Aspm -5.7 0.00153 
 
Dudakovic et al., 2013 
Epithelial cell transforming sequence 2 oncogene  Ect2 -5.7 9.54E-04  
Centrosomal protein 55  Cep55 -5.6 0.00190  
Kinesin family member 20B  Kif20b -5.6 0.00303  
Protein regulator of cytokinesis 1  Prc1 -5.6 4.66E-04  
Kinesin family member 20A  Kif20a -5.5 0.00222 LaBonte et al., 2009, 
Majumdar et al., 2012 
Ubiquitin-conjugating enzyme E2T (putative)  Ube2t -5.4 8.76E-04 Schroeder et al., 2007 
MMS22-like, DNA repair protein  Mms221 -5.4 2.01E-04  
ASF1 anti-silencing function 1 homolog B (S. cerevisiae)  Asf1b -5.4 0.00170  
GINS complex subunit 1 (Psf1 homolog)  Gins1 -5.3 4.08E-04  
Transforming, acidic coiled-coil containing protein  Tacc3 -5.3 0.00238  
Rattus norvegicus histone cluster 2, H3c2  Hist2h3c2 -5.2 3.40E-05  
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Table 4 Top 20 known genes induced by SAHA in mineralizing rat DPC cultures at 14 days. 
References are for previous studies that reported up-regulation of the transcript or protein in cells or 
other cell systems by an HDACi. 
 
 
 
 
 
 
 
 
 
 
Gene Gene 
name 
Fold 
change 
t-test with 
Storey 
Up-regulation Reported 
Reference* 
Inositol polyphosphate-4-phosphatase, type II Inpp4b 3.7 0.00732  
Disabled homolog 1 (Drosophila)  Dab1 3.6 0.00163 Koutsounas et al., 2013 
BCL2 interacting protein harakiri  Hrk 2.9 0.00391  
T-cell differentiation protein 2  Mal2 2.8 0.00442  
Glutamate receptor, ionotropic, kainate 4 Grik4 2.8 0.00484  
Aquaporin 3 Aqp3 2.5 9.34E-04  
Purinergic receptor P2X, ligand-gated ion channel, 2  P2rx2 2.4 0.00207  
RAS guanyl releasing protein 3 (calcium and DAG-regulated)  Rasgrp3 2.3 0.00204 Moore et al., 2004 
Solute carrier organic anion transporter family, member 4a1  Slco4a1 2.1 0.00696  
Agmatine ureohydrolase (agmatinase)  Agmat 2.1 0.00548  
Catenin (cadherin-associated protein), delta 2  Ctnnd2 2.0 0.00436  
Cd5 molecule-like  Cd5l 2.0 0.00124  
Coiled-coil domain containing 67  Ccdc67 1.9 0.00276  
Prolyl 4-hydroxylase, alpha polypeptide I  P4ha1 1.9 0.00242  
S100 calcium binding protein A11 (calizzarin)  S100a11 1.9 9.81E-04  
Ameloblastin Ambn 1.9 5.35E-04  
Tenascin C  Tnc 1.8 0.0014  
EF-hand domain family, member D1  Efhd1 1.8 6.01E-04  
Thy-1 cell surface antigen  Thy1 1.8 2.52E-04  
Cytoplasmic FMR1 interacting protein 2  Cyfip2 1.8 0.00417  
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Table 5 Top 20 known genes suppressed by SAHA in mineralizing rat DPC cultures at 14 days. 
References are for previous studies that reported down-regulation of the transcript or protein in cells 
or other cell systems by an HDACi (*). 
 
 
 
 
 
 
 
 
 
 
 
 
Gene Gene 
name 
Fold 
change 
t-test with 
Storey 
Downegulation 
Reported Reference* 
Keratin 18  Krt18 -2.8 0.001  
Olfactory receptor 1749  Olr1749 -2.5 2.96E-04  
Eph receptor A3  Epha3 -2.4 0.008 Poulaki et al., 2009 
G protein-coupled receptor 137C  Gpr137c -2.1 0.00265  
Vomeronasal 1 receptor 68  Vom1r68 -2.1 0.00598  
Myosin light chain kinase  Mylk -2.0 0.00359  
Olfactory receptor 777  Olr777 -1.9 0.00885  
G-protein signalling 4 Rgs4 -1.9 0.002  
Interphotoreceptor matrix proteoglycan 1  Impg1 -1.9 0.00428  
Transmembrane 4 L six family member 20  Tm4sf20 -1.9 4.37E-04  
Somatostatin receptor 2  Sstr2 -1.9 0.00214  
Forkhead box A3  Foxa3 -1.9 0.00163  
Purkinje cell protein 4 , transcript variant 1 Pcp4 -1.9 0.00311  
Aldehyde dehydrogenase 1 family, member A2 Aldh1a2 -1.9 0.00668  
Zinc finger and BTB domain containing 38 Zbtb38 -1.8 0.00175  
Upper zone of growth plate and cartilage matrix associated Ucma -1.8 6.97E-04  
Cytochrome P450, family 4, subfamily a, polypeptide 8  Cyp4a8 -1.8 0.00131  
Leucine rich repeat neuronal 2  Lrm2 -1.8 0.00422  
Signal transducer and activator of transcription 6 Stat6 -1.8 0.00733  
Protamine 2 (Prm2) Prm2 -1.8 0.00151  
Insulin-like growth factor binding protein 3  Igfgp3 -1.8 1.38E-04  
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Table 6 Over-represented pathways (genes > 2 fold) at 24h, analysed using GoElite software. In order 
to remove falsely over-represented pathways results were filtered by the number genes changed (>2), 
Z Score (>1.96), and PermuteP (<0.05). These pruned results minimize redundant terms and 
pathways. Over-represented upregulated pathways marked with asterisk (*). 
 
 
 
 
 
 
 
 
Gene Number 
changed 
% changed z-score PermuteP 
Cell cycle 17 39 11.9 0.0001 
DNA Replication 11 41 9.8 0.0001 
G1 to S cell cycle control 13 31 9.0 0.0001 
Mismatch repair 3 50 5.75 0.0005 
Homologous recombination 4 36                       5.48 0.0005 
Hedgehog Signalling Pathway 3 25 3.71 0.0035 
Matrix Metalloproteinases* 3 16.7 2.75 0.0085 
Endochondral Ossification* 4 12.9 2.55 0.0085 
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Table 7 A comparison of cDNA gene expression microarray and validatory qRT-PCR at 24 h and 14 
days. n=4 for both sets of experiments. 
 
Gene Fold change cDNA microarray (24h) Fold change RT-PCR (24h) 
Adm 3.4 3.06 
BMP-4 1.9 2.79 
Dab1 4.13 5.17 
Gsta4 8.21 14.5 
Hist1h1b -7.83 -13.0 
IBSP 2.2 2.38 
Krt18 -2.8 -2.75 
Mcm10 15.72 -14.3 
Mmp9 3.0 2.76 
Mmp13 2.45 2.19 
Nestin 1.1 1.82 
Rap2ip 8.9 14.91 
Rasgrp3 1.3 1.15 
Ska1 -97.2 -72.5 
TGFβ2 2.78 3.76 
Tspan13 4.84 6.35 
Gene 
 
Fold change cDNA microarray (14d) Fold change RT-PCR (14d) 
 
Ambn 1.88 1.72 
Epha3 -2.4 -2.06 
Krt18 -2.8 -2.65 
Mal2 2.83 2.73 
Mmp13 1.61 1.05 
Rasgrp13 2.33 2.32 
Spp-1 1.1 1.29 
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Fig. 1A  
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Fig. 1B  
258x168mm (96 x 96 DPI)  
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Fig. 1C  
258x169mm (96 x 96 DPI)  
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Fig. 1D  
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Fig. 1E  
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